Aptevo Therapeutics Inc.
APVO | NASDAQ
$1.84
$0 (0.00%)
At close: Sep 21, 2026, 3:59 PM ET
$1.88
+$0.04 (+2.28%)
Pre-market:
Sep 22, 2026, 4:14 AM ET
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 3.11M | 6.78M | 9.88M | 12.99M | 12.29M | 11M | 9.37M | 6.73M |
Cost of Revenue | 116K | 116K | 81K | 71K | 71K | 71K | 177K | 106K | 106K | 106K | n/a | n/a | n/a | n/a | 4.87M | 9.41M | 13.78M | 18.5M | 18.99M | 19.36M | 19.49M | 14.77M |
Gross Profit | -116K | -116K | -81K | -71K | -71K | -71K | -177K | -106K | -106K | -106K | n/a | n/a | n/a | n/a | -1.75M | -2.63M | -3.9M | -5.51M | -6.7M | -8.36M | -10.12M | -8.04M |
Operating Income | -26.89M | -26.67M | -26.31M | -26.7M | -24.3M | -24.1M | -24.6M | -24.6M | -25.95M | -28.11M | -28.88M | -30.18M | -31.4M | -30.79M | -28.64M | -25M | -21.96M | -20.12M | -21.4M | -24.18M | -25.68M | -26.76M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -26.41M | -26.26M | -25.97M | -26.47M | -24.03M | -23.7M | -24.13M | -24.01M | -25.25M | -27.31M | -18.65M | -17.62M | -19.09M | 16.72M | 7.01M | 5.58M | 6.31M | -29.61M | -29.41M | -29.98M | -29.85M | -28.59M |
Net Income | -26.41M | -26.26M | -25.97M | -26.47M | -24.03M | -23.7M | -24.13M | -23.72M | -24.95M | -27.02M | -17.41M | -16.15M | -17.46M | 18.5M | 8.03M | 6.4M | 7.04M | -28.9M | -28.46M | -29.24M | -29.03M | -27.9M |
Selling & General & Admin | 11.69M | 11.84M | 11.77M | 11.81M | 10.36M | 9.84M | 10.22M | 10.52M | 11.08M | 11.41M | 11.77M | 11.99M | 12.62M | 13.6M | 13.87M | 14.03M | 14.2M | 14.61M | 14.7M | 15.82M | 15.55M | 14.28M |
Research & Development | 15.16M | 14.8M | 14.54M | 14.89M | 13.94M | 14.26M | 14.27M | 13.98M | 14.77M | 16.59M | 17.11M | 18.19M | 18.78M | 17.18M | 17.88M | 17.75M | 17.64M | 18.5M | 18.99M | 19.36M | 19.49M | 19.21M |
Other Expenses | -81K | -81K | -81K | -71K | -71K | -71K | -71K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -4.87M | -9.41M | -13.78M | -18.5M | -18.99M | -19.36M | -19.49M | -14.77M |
Operating Expenses | 26.77M | 26.55M | 26.23M | 26.63M | 24.23M | 24.03M | 24.43M | 24.5M | 25.85M | 28M | 28.88M | 30.18M | 31.4M | 30.79M | 26.89M | 22.37M | 18.06M | 14.61M | 14.7M | 15.82M | 15.55M | 18.72M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 26.89M | 26.67M | 26.31M | 26.7M | 24.3M | 24.1M | 24.6M | 24.6M | 25.95M | 28.11M | 28.88M | 30.18M | 31.4M | 30.79M | 31.76M | 31.78M | 31.84M | 33.11M | 33.69M | 35.18M | 35.04M | 33.49M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 1.2M | 1.06M | 997.83K | 224.95K | 41.01K | 4.05K | 4.05K | 791.93 | 264.25 | 51.56 | 33.22 | 21.46 | 11.06 | 11.98 | 11.03 | 8.69 | 8.57 | 8.42 | 8.36 | 8.35 | 7.74 | 7.54 |
Shares Outstanding (Diluted) | 1.2M | 1.06M | 997.83K | 224.95K | 41.01K | 4.05K | 4.05K | 791.93 | 264.25 | 51.56 | 33.22 | 21.46 | 11.06 | 11.98 | 11.03 | 8.69 | 8.57 | 8.42 | 8.36 | 8.35 | 7.74 | 7.54 |
EPS (Basic) | -211.18 | -357.16 | -1.93K | -3.33K | -9.73K | -31.84K | -162.81K | -338.96K | -627.63K | -1.32M | -959.99K | -1.2M | -1.79M | 2.2M | 1.05M | 723.82K | 765.58K | -3.53M | -3.58M | -3.83M | -4.23M | -4.43M |
EPS (Diluted) | -211.18 | -357.16 | -1.93K | -3.33K | -9.73K | -31.84K | -162.81K | -338.96K | -627.63K | -1.32M | -959.99K | -1.2M | -1.79M | 2.2M | 1.05M | 723.82K | 765.58K | -3.53M | -3.58M | -3.83M | -4.23M | -4.43M |
EBITDA | -26.42M | -26.04M | -25.73M | -26.24M | -23.76M | -23.4M | -23.78M | -23.62M | -24.81M | -26.82M | -18.08M | -17.01M | -18.38M | 17.55M | 7.92M | 6.58M | 7.38M | -28.52M | -27.48M | -27.72M | -26.88M | -25.62M |
EBIT | -26.58M | -26.26M | -25.97M | -26.47M | -24.03M | -23.7M | -24.13M | -24.01M | -25.25M | -27.31M | -18.65M | -17.62M | -19.09M | 16.72M | 7.01M | 5.58M | 6.31M | -29.61M | -28.63M | -28.85M | -28.02M | -26.76M |
Depreciation & Amortization | 165K | 214K | 240K | 230K | 265K | 307K | 352K | 397K | 436K | 495K | 567K | 612K | 711K | 837K | 901K | 996K | 1.07M | 1.09M | 1.14M | 1.13M | 1.14M | 1.15M |
Add to Watchlist
Select watchlists to add or remove APVO